Denis Drygin
Plus aucun poste en cours
Historique de carrière de Denis Drygin
Anciens postes connus de Denis Drygin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REGULUS THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 03/08/2020 | 29/11/2022 |
Pimera, Inc.
 Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Fondateur | 01/01/2013 | 31/07/2020 |
| Corporate Officer/Principal | 01/01/2013 | 31/07/2020 | |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formation de Denis Drygin
| University of Massachusetts | Doctorate Degree |
| Moscow State University Lomonosov | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Russie | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Pimera, Inc.
Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Finance |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Denis Drygin
- Expérience
